MedTrace Logo

Behavioral Pharmacology of Cannabis in Older Adults

NCT06055309 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-01-14

No results posted yet for this study

Summary

This study examines the effects of cannabis on mood, cognitive and psychomotor performance, balance and vital signs in older adults.

Conditions

  • Health Services for the Aged

Interventions

DRUG

Cannabis (up to three doses)

a dose of cannabis will be baked into brownies

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Alison Oliveto, PhD · University of Arkansas

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06055309 on ClinicalTrials.gov